The Peptide NewsroomPeptide research, industry and supply-chain headlines

Glutathione Review Says Peptide Antioxidant May Do More Than Scavenge in Fresh-Cut Produce

Topic card: glutathione recovery

A mini-review published in Frontiers in Nutrition argues that glutathione does more in cut fruits and vegetables than soak up free radicals, and that postharvest research has been treating it as a simple chemical additive. The authors, based at Shaoguan University in China, propose it functions instead as what they call a homeostatic orchestrator.

Glutathione, usually written GSH, is a non-protein tripeptide thiol found throughout the plant kingdom. The browning everyone is trying to stop is enzymatic, driven mainly by polyphenol oxidase and peroxidase attacking phenolic compounds once a knife breaks open the cells. One important caveat lands early: because the literature on GSH in fresh-cut produce is thin, several of the mechanisms here are inferred from model plant systems such as Arabidopsis thaliana rather than measured in the crops themselves.

What the treatments did

The review collects studies where GSH was applied directly by dipping, spraying or vacuum infiltration. A 1% weight/volume application on fresh-cut lotus root slices significantly delayed surface discoloration in cold storage while preserving higher internal ascorbic acid, and a 1% dip on fresh-cut wax apple reduced browning incidence and slowed the decline in tissue lightness under refrigeration.

Combinations did better than either component alone. Treating fresh-cut lotus rhizome with 40-kHz ultrasonication for 2 minutes alongside a lower 0.5% GSH concentration inhibited cut-surface browning far more effectively than GSH or ultrasound on its own.

Beyond scavenging

The more interesting argument is mechanistic. The authors describe GSH potentially intervening downstream too: kinetic studies have reported it acting as a mixed-type or non-competitive inhibitor of plant polyphenol oxidases, and it can react with enzyme-generated o-quinones to form colorless conjugates such as 2-S-glutathionyl chlorogenic acid, which may not serve as substrates for further oxidation.

Limitations

This is a mini-review, not new experimental work, and the authors are explicit that direct evidence across diverse fresh-cut horticultural products is still required. They also flag a messy detail in the enzyme data: in purified apple polyphenol oxidase work, the observed inhibition by GSH was largely attributable to a drop in reaction pH under the conditions tested, not to the peptide itself.

Bottom line

The proposal is that GSH metabolism is a target worth engineering rather than an additive worth buying. Whether that holds outside Arabidopsis and a handful of crops is unsettled.

Source: Frontiers in Nutrition. Read the original.

Filed under: recovery

Comments (0)

Discussion happens on Reddit.
Questions and corrections go to r/PeptideNewsroom.

Go to r/PeptideNewsroom

Corrections are the most useful thing you can post. Comments touching dosing, sourcing or links are held for a moderator first.

More from The Peptide Newsroom

Peptide Buyers Are Injecting Drug Users Now, But Few See Themselves That Way

Researchers writing in The Conversation say peptide buyers are injecting drugs without recognizing themselves as injectors, and report New South Wales hospitalizations rising from five in July 2025 to more than 200 in September 2026. Needle and syringe programs are absorbing the demand on budgets built for a different era.

Peptide Sciences Closure Draws a Clinic Press Release, and a Useful Regulatory Reminder

A telehealth clinic has built a press release around the reported March 2026 closure of research-peptide vendor Peptide Sciences, pitching physician-guided consultations to its former customers. The commercial motive is obvious, but the regulatory points about BPC-157, tesamorelin and compounded medications are more carefully stated than most.

Hawaii Rehab Adds Peptide Therapy to Addiction Care, But the Release Names No Peptide

Exclusive Hawaii Rehab says its peptide therapy program is one part of an integrated approach to addiction and mental health care, offered only after medical evaluation. The release names no specific peptide, cites no study, and carries its own FDA caveat.